Skip to content

Pulsatile Flushing Technique in Reducing Blockage of T-CVAD for Haemodialysis Patients

Exploring the Effectiveness of Pulsatile Flushing Technique in Reducing Blockage of the Tunnelled Central Venous Access Device Among Haemodialysis Patients in Multiple Renal Centres in Hong Kong: A Cluster Non-Randomised Controlled Trial Study

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07567456
Acronym
Non-RCT HD
Enrollment
591
Registered
2026-05-05
Start date
2026-02-02
Completion date
2027-12-01
Last updated
2026-05-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Blockage of Tunnelled Central Venous Access Device, Haemodialysis Patients, Pulsatile Flushing Technique

Keywords

HD, T-CVAD, Pulsatile Flushing Technique

Brief summary

This study investigates the effectiveness of pulsatile flushing techniques in reducing blockage in Tunnelled Central Venous Access Device (T-CVAD) among patients undergoing haemodialysis (HD) treatment at multiple renal centres within the Hospital Authority (HA) in Hong Kong. With limitation in single service protocol for each cluster of renal units, it is designed as a prospective, parallel, cluster non-randomised controlled trial involving 591 patients from 14 renal units. In order to identify the most effective flushing technique for T-CVAD maintenance, survival analysis on clinical effectiveness, in terms time-to-event blockage of the T-CVAD, among three trial arms: 1) Intervention Group A (IG-A) using pulsatile flushing technique with 0.4 second pause time interval; 2) Intervention Group B (IG-B) using pulsatile flushing technique with 1 second pause time interval; 3) Control Group (Con) using standard bolus flushing technique. The findings facilitate development of best practice for T-CVAD maintenance, optimise T-CVAD maintenance protocols, and ultimately improve patient outcomes. This groundbreaking study is expected to signify substantial progression in the nursing management of HD and T-CVAD.

Interventions

DEVICEPulsatile Flushing Technique (0.4s pause interval)

Pulsatile flushing technique consists of multiple small boluses injected intermittently with 0.4-second pauses between each bolus resulting in unsteady turbulent flow, performed by a renal nurse who passed a formal train-the-trainer program on "pulsatile flushing technique" taught and assessed by designated nurse consultant (renal care).

OTHERPulsatile Flushing Technique (1s pause interval)

Pulsatile flushing technique consists of multiple small boluses injected intermittently with 1-second pauses between each bolus resulting in unsteady turbulent flow, performed by a renal nurse who passed a formal train-the-trainer program on "pulsatile flushing technique" taught and assessed by designated nurse consultant (renal care).

DEVICEBolus Flushing Technique

Bolus flushing technique involves the continuous administration of a single, concentrated volume of flush solution resulting in consistent laminar flow

Sponsors

Queen Elizabeth Hospital, Hong Kong
Lead SponsorOTHER
Kwong Wah Hospital
CollaboratorOTHER
Prince of Wales Hospital, Shatin, Hong Kong
CollaboratorOTHER
Alice Ho Miu Ling Nethersole Hospital
CollaboratorOTHER
North District Hospital, Hong Kong
CollaboratorUNKNOWN
Caritas Medical Centre, Hong Kong
CollaboratorOTHER
Queen Mary Hospital, Hong Kong
CollaboratorOTHER
Tseung Kwan O Hospital, Hong Kong
CollaboratorOTHER
Tin Shui Wai Hospital
CollaboratorUNKNOWN
Yan Chai Hospital
CollaboratorOTHER
Tung Wah Hospital
CollaboratorOTHER
Pamela Youde Nethersole Eastern Hospital
CollaboratorOTHER
Tuen Mun Hospital
CollaboratorOTHER_GOV
Princess Margaret Hospital, Hong Kong
CollaboratorOTHER_GOV

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Intervention model description

Paralleled Cluster Non-Randomized Controlled Trial

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients undergoing HD treatment with Tunnelled Central Venous Access Device (T-CVAD) in the above collaborators under the Hospital Authority * Able to understand spoken and written Chinese or English

Exclusion criteria

* Patients with Non-Tunnelled Central Venous Access Device (NT-CVAD) * Temporary dysfunction (e.g., kicking of the catheter) resolved with repositioning * Confirmed case of fibrin sheath occlusion which can only be resolved through surgical intervention * Non-thrombotic occlusion due to mechanical causes (e.g., catheter malposition) * Patient declined or incompetent to provide written informed consent.

Design outcomes

Primary

MeasureTime frameDescription
Time-to-event T-CVAD BlockageFrom the date of recruitment until the end of the study (at least 1-year follow-up) or date of termination (e.g., blockage, death, refusal to participate in the study… etc) whichever comes earlier, assessed up to 24 months.as measured by time to the first occurrence of blockage of Tunnelled Central Venous Access Device (T-CVAD). T-CVAD blockage episodes can be transformed to incidence rates (in episodes per patient-year), or presented by Kaplan-Meier analysis with median blockage-free survival statistics stratified by three trial arms.

Countries

Hong Kong

Contacts

CONTACTSUNG Ka Ming Dorothy, KCC NC (Renal Care)
bskmd01@ha.org.hk852-3506

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 12, 2026